Liver-Targeting Class I Selective Histone Deacetylase Inhibitors Potently Suppress Hepatocellular Tumor Growth as Standalone Agents

SIMPLE SUMMARY: Liver cancers are among the leading causes of global cancer deaths. The current therapy options for liver cancers, including hepatocellular carcinoma (HCC), which accounts for over 80% of all cases, have afforded limited benefit to patients with an advanced disease state. HCC results...

Descripción completa

Detalles Bibliográficos
Autores principales: Tapadar, Subhasish, Fathi, Shaghayegh, Wu, Bocheng, Sun, Carrie Q., Raji, Idris, Moore, Samuel G., Arnold, Rebecca S., Gaul, David A., Petros, John A., Oyelere, Adegboyega K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7690782/
https://www.ncbi.nlm.nih.gov/pubmed/33114147
http://dx.doi.org/10.3390/cancers12113095

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7690782/
https://www.ncbi.nlm.nih.gov/pubmed/33114147
http://dx.doi.org/10.3390/cancers12113095

Ejemplares similares